IL208836A0 - Long-acting y2 and/or y4 receptor agonists - Google Patents

Long-acting y2 and/or y4 receptor agonists

Info

Publication number
IL208836A0
IL208836A0 IL208836A IL20883610A IL208836A0 IL 208836 A0 IL208836 A0 IL 208836A0 IL 208836 A IL208836 A IL 208836A IL 20883610 A IL20883610 A IL 20883610A IL 208836 A0 IL208836 A0 IL 208836A0
Authority
IL
Israel
Prior art keywords
acting
long
receptor agonists
agonists
receptor
Prior art date
Application number
IL208836A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL208836A0 publication Critical patent/IL208836A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL208836A 2008-05-16 2010-10-20 Long-acting y2 and/or y4 receptor agonists IL208836A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08156360 2008-05-16
EP09154461 2009-03-05
PCT/EP2009/055989 WO2009138511A1 (en) 2008-05-16 2009-05-18 Long-acting y2 and/or y4 receptor agonists

Publications (1)

Publication Number Publication Date
IL208836A0 true IL208836A0 (en) 2011-01-31

Family

ID=40934036

Family Applications (1)

Application Number Title Priority Date Filing Date
IL208836A IL208836A0 (en) 2008-05-16 2010-10-20 Long-acting y2 and/or y4 receptor agonists

Country Status (12)

Country Link
US (1) US20110275559A1 (cg-RX-API-DMAC7.html)
EP (1) EP2279204A1 (cg-RX-API-DMAC7.html)
JP (1) JP2011520847A (cg-RX-API-DMAC7.html)
KR (1) KR20110017874A (cg-RX-API-DMAC7.html)
CN (1) CN102027007A (cg-RX-API-DMAC7.html)
AU (1) AU2009248041B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0912615A2 (cg-RX-API-DMAC7.html)
CA (1) CA2723855A1 (cg-RX-API-DMAC7.html)
IL (1) IL208836A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010011845A (cg-RX-API-DMAC7.html)
RU (1) RU2504550C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009138511A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5767582B2 (ja) 2009-07-02 2015-08-19 武田薬品工業株式会社 ペプチド及びその用途
US20130040877A1 (en) * 2009-09-18 2013-02-14 Novo Nordisk A/S Long-acting y2 receptor agonists
CN102905722A (zh) * 2009-11-13 2013-01-30 诺沃—诺迪斯克有限公司 长效y2受体激动剂
GB201001333D0 (en) * 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
WO2012006566A2 (en) 2010-07-09 2012-01-12 Amylin Pharmaceuticals, Inc. Microcrystalline y receptor agonists
HUE036066T2 (hu) 2010-12-16 2018-06-28 Novo Nordisk As GLP-1 agonistát és N-(8-(2-hidroxibenzoil)amino)kaprilsav sóját tartalmazó szilárd készítmények
HRP20181447T1 (hr) 2012-03-22 2018-11-02 Novo Nordisk A/S Pripravci glp-1 peptida i njihova priprava
MY172578A (en) 2013-05-02 2019-12-03 Novo Nordisk As Oral dosing of glp-1 compounds
EP2842965A1 (en) 2013-09-03 2015-03-04 Gubra ApS Neuromedin U analogs comprising serum albumin binding amino acid residue
WO2015073878A1 (en) * 2013-11-15 2015-05-21 Ur Diet, Llc Real-time satiety biofeedback
PT3068421T (pt) * 2013-11-15 2019-07-11 Novo Nordisk As Compostos de pyy eletivo e usos dos mesmos
EP3068795B1 (en) 2013-11-15 2019-03-06 Novo Nordisk A/S Hpyy(1-36) having a beta-homoarginine substitution at position 35
RS59026B1 (sr) 2013-11-15 2019-08-30 Novo Nordisk As Selektivna pyy jedinjenja i njihova upotreba
US20240100450A9 (en) * 2014-01-17 2024-03-28 Repligen Corporation Sterilizing chromatography columns
KR102393642B1 (ko) 2014-01-17 2022-05-03 리플리겐 코포레이션 크로마토그래피 컬럼 살균
EP3145523A4 (en) * 2014-05-21 2018-02-21 President and Fellows of Harvard College Ras inhibitory peptides and uses thereof
CA2988500A1 (en) * 2015-06-12 2016-12-15 Novo Nordisk A/S Selective pyy compounds and uses thereof
RS64643B1 (sr) 2018-02-02 2023-10-31 Novo Nordisk As Čvrste kompozicije koje sadrže glp-1 agonist i so n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline i lubrikant
TW202535916A (zh) 2018-11-01 2025-09-16 美商美國禮來大藥廠 蛋白質酪胺酸-酪胺酸類似物及其使用方法
GB201908426D0 (en) * 2019-06-12 2019-07-24 Imp College Innovations Ltd Appetite suppressing compounds
MX2022013024A (es) * 2020-04-17 2023-03-15 I2O Therapeutics Inc Analogos del peptido tirosina tirosina (pyy) de accion prolongada y metodos de uso de los mismos.
EP4329812A1 (en) 2021-04-27 2024-03-06 Aardvark Therapeutics Inc. Combination of bitter receptor agonist and gut-signaling compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2275207C2 (ru) * 2000-12-14 2006-04-27 Амилин Фармасьютикалз, Инк. Способ снижения доступности питательного вещества, способ подавления аппетита
AU2004273573B2 (en) * 2003-09-19 2010-04-22 Novo Nordisk A/S Albumin-binding derivatives of therapeutic peptides
JP5638177B2 (ja) * 2004-02-11 2014-12-10 アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc 膵臓ポリペプチドファミリーモチーフおよびそのモチーフを含むポリペプチド
MXPA06010345A (es) * 2004-03-17 2007-06-19 7Tm Pharma As Agonistas de receptor selectivo de y4 para intervenciones terapeuticas.
AU2005261740A1 (en) * 2004-07-08 2006-01-19 Novo Nordisk A/S Polypeptide protracting tags comprising a tetrazole moiety
CN101222942A (zh) * 2005-07-18 2008-07-16 诺沃-诺迪斯克有限公司 用于治疗肥胖的肽

Also Published As

Publication number Publication date
WO2009138511A1 (en) 2009-11-19
CN102027007A (zh) 2011-04-20
EP2279204A1 (en) 2011-02-02
RU2010149474A (ru) 2012-06-27
AU2009248041A1 (en) 2009-11-19
MX2010011845A (es) 2010-11-22
BRPI0912615A2 (pt) 2016-01-26
KR20110017874A (ko) 2011-02-22
JP2011520847A (ja) 2011-07-21
CA2723855A1 (en) 2009-11-19
RU2504550C2 (ru) 2014-01-20
AU2009248041B2 (en) 2013-10-03
US20110275559A1 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
IL208836A0 (en) Long-acting y2 and/or y4 receptor agonists
IL213569A0 (en) Gpr120 receptor agonists and uses thereof
EP2173174A4 (en) FARNESOID X RECEPTOR AGONISTS
EP2170072A4 (en) Farnesoid X RECEPTOR AGONISTS
IL208919A0 (en) Gpr119 receptor agonists
EP2306994A4 (en) S1P1 RECEPTOR AGONISTS AND USES
IL210506A0 (en) Complement antagonists and uses thereof
IL209785A0 (en) Aryl gpr119 agonists and uses thereof
PL2318366T3 (pl) Środki wiążące PSMA i ich zastosowania
ZA201101896B (en) Frizzled-binding agents and uses thereof
IL210773A0 (en) Neuropeptide-2 receptor (y-2r) agonists and uses thereof
EP2318618A4 (en) construction support
ZA201103154B (en) Melanocortin receptor agonists
IL209492A0 (en) Personal load carrying release
GB0822154D0 (en) Recepatacle and support
IL212364A0 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
EP2262371A4 (en) LPA RECEPTOR AGONISTS AND ANTAGONISTS
EP2247601A4 (en) THIAZOPYRIMIDINONE AND APPLICATIONS THEREOF
GB2458890B (en) Support anchor
GB0814548D0 (en) Tile and tile holding device
AU4585P (en) WES05 Westringia fruticosa
GB0807710D0 (en) Receptor and modulators thereof
GB0818393D0 (en) Dispenser and support member
AU320444S (en) Tilting bollard
HU0800405D0 (en) Ewnvironment-friendly biocidis and use thereof